Adverse event assessment in prostate cancer patients receiving androgen deprivation therapy: are we doing enough?
Author:
Publisher
Edizioni Minerva Medica
Subject
Urology,Nephrology
Link
https://www.minervamedica.it/pdf.php?cod=R19Y2021N06A0870
Reference10 articles.
1. Androgen deprivation therapy prescription, blood and bone-density testing in a French population-based study exploring adherence to the French prostate cancer guidelines
2. Hormonal treatment and quality of life of prostate cancer patients: new evidence
3. Muscle and bone effects of androgen deprivation therapy: current and emerging therapies
4. Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group
5. Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries;Minerva Urology and Nephrology;2023-09
2. How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?;Research and Reports in Urology;2023-01
3. The current evidence on prognostic factors in metastatic castration-resistant prostate cancer patients treated with Radium-223;Minerva Urology and Nephrology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3